[Glycopeptides (vancomycin, teicoplanin)].
Furuta
Itaru
I
Department of Laboratory Medicine, Kinki University School of Medicine.
Kitahashi
Toshihiro
T
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood* / Q000493:pharmacokinetics; D015415:Biomarkers / Q000097:blood; D002851:Chromatography, High Pressure Liquid; D016903:Drug Monitoring / Q000379:methods*; D019075:Electrophoresis, Capillary; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism; D012016:Reference Values; D013048:Specimen Handling; D017334:Teicoplanin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood* / Q000493:pharmacokinetics; D014640:Vancomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood* / Q000493:pharmacokinetics
D000900:Anti-Bacterial Agents; D015415:Biomarkers; D017334:Teicoplanin; D014640:Vancomycin